- Ansys: RBC Capital Markets raised the target to $425 from $380. Maintains sector perform rating.
- BP Plc: Jefferies maintained his recommendation on the stock with a Neutral rating. The target price differs slightly and is now set at GBp 360 versus GBp 350.
- Citrix: Morgan Stanley downgrades to underweight from equal-weight. PT down 11% to $85
- CyberArk: Wedbush goes long and raises its target from USD 200 to 230.
- Evercore: UBS upgrades its buy rating to neutral but raises its target price from USD 148 to USD 155.
- GlaxoSmithKline: Barclays raises its opinion on the stock and goes from selling to neutral. The target price is revised upwards from GBp 1600 to GBp 1400.
- London Stock Exchange: Goldman Sachs upgrades his rating from Sell to Buy. The target price continues to be set at GBp 8695.
- Microchip: Truist Securities upgrades to $94 from $88. Maintains buy rating.
- Nikola: BTIG downgrades to Neutral From Buy
- Novartis: UBS cut the recommendation to neutral from buy. PT up 4.5% to 80 Swiss francs
- Papa John's: Deutsche Bank downgrades to hold from buy. PT down 2.9% to $136
- Peloton Interactive: Wedbush lowers Price Target to $66 From $90, maintains Neutral Rating
- Qiagen: Invest Securities cut the recommendation to hold from buy. PT up 5.8% to $58.89
- Qualcomm: DZ Bank AG upgrades to buy from hold. PT up 7.6% to $168
- Regeneron: Benchmark Company cut the recommendation on Regeneron Pharmaceuticals to hold from buy.
- Shake Shack: Oppenheimer & Co cut the price target on Shake Shack Inc. Class A to $100 from $115. Maintains outperform rating.